5 research outputs found
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program
No full textClinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib
No full textBosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
No full textNeutrophilic Dermatosis of the Dorsal Hands Associated with a “Myeloproliferative Neoplasm, Unclassifiable“ and a Simultaneous Cancer of Colon
No full textNeutrophilic dermatosis of the dorsal hands is a variant of Sweet's syndrome. We herein describe an 83-year old woman with a neutrophilic dermatosis of the dorsal hands associated with a "myeloproliferative neoplasm, unclassifiable" and a simultaneous cancer of colon. To our knowledge, and after a search in PubMed, the association of Sweet's syndrome with a "myeloproliferative neoplasm, unclassifiable" and a simultaneous cancer of colon has not previously been reported
